全文获取类型
收费全文 | 281篇 |
免费 | 13篇 |
专业分类
儿科学 | 5篇 |
妇产科学 | 1篇 |
基础医学 | 33篇 |
口腔科学 | 1篇 |
临床医学 | 16篇 |
内科学 | 80篇 |
皮肤病学 | 5篇 |
神经病学 | 15篇 |
特种医学 | 2篇 |
外科学 | 39篇 |
综合类 | 2篇 |
预防医学 | 48篇 |
眼科学 | 6篇 |
药学 | 9篇 |
肿瘤学 | 32篇 |
出版年
2023年 | 2篇 |
2022年 | 4篇 |
2021年 | 12篇 |
2020年 | 4篇 |
2019年 | 15篇 |
2018年 | 8篇 |
2017年 | 8篇 |
2016年 | 5篇 |
2015年 | 11篇 |
2014年 | 15篇 |
2013年 | 18篇 |
2012年 | 29篇 |
2011年 | 21篇 |
2010年 | 14篇 |
2009年 | 4篇 |
2008年 | 14篇 |
2007年 | 23篇 |
2006年 | 21篇 |
2005年 | 15篇 |
2004年 | 9篇 |
2003年 | 12篇 |
2002年 | 7篇 |
2001年 | 6篇 |
2000年 | 4篇 |
1999年 | 4篇 |
1998年 | 2篇 |
1997年 | 2篇 |
1995年 | 2篇 |
1992年 | 1篇 |
1978年 | 1篇 |
1968年 | 1篇 |
排序方式: 共有294条查询结果,搜索用时 15 毫秒
71.
72.
Bernhardt JM Usdan S Mays D Arriola KJ Martin RJ Cremeens J McGill T Weitzel JA 《Addictive behaviors》2007,32(12):3065-3070
The present study sought to test the feasibility of measuring quantity and frequency of self-reported alcohol consumption among college students using the Handheld Assisted Network Diary (HAND) by comparing results to a retrospective Timeline Followback (TLFB). A total of 40 undergraduate college students completed a HAND assessment during the two-week study period and completed a TLFB at follow-up. The HAND recorded similar levels of alcohol consumption compared to the TLFB. There were no significant differences in overall alcohol consumption, drinks per drinking day, or heavy drinking days between the two methods of assessment. Handheld computers may represent a useful tool for assessing daily alcohol use among college students. 相似文献
73.
Duran M Pérez E Abanades S Vidal X Saura C Majem M Arriola E Rabanal M Pastor A Farré M Rams N Laporte JR Capellà D 《British journal of clinical pharmacology》2010,70(5):656-663
AIMS
Despite progress in anti-emetic treatment, many patients still suffer from chemotherapy-induced nausea and vomiting (CINV). This is a pilot, randomized, double-blind, placebo-controlled phase II clinical trial designed to evaluate the tolerability, preliminary efficacy, and pharmacokinetics of an acute dose titration of a whole-plant cannabis-based medicine (CBM) containing delta-9-tetrahydrocannabinol and cannabidiol, taken in conjunction with standard therapies in the control of CINV.METHODS
Patients suffering from CINV despite prophylaxis with standard anti-emetic treatment were randomized to CBM or placebo, during the 120 h post-chemotherapy period, added to standard anti-emetic treatment. Tolerability was measured as the number of withdrawals from the study during the titration period because of adverse events (AEs). The endpoint for the preliminary efficacy analysis was the proportion of patients showing complete or partial response.RESULTS
Seven patients were randomized to CBM and nine to placebo. Only one patient in the CBM arm was withdrawn due to AEs. A higher proportion of patients in the CBM group experienced a complete response during the overall observation period [5/7 (71.4%) with CMB vs. 2/9 (22.2%) with placebo, the difference being 49.2% (95% CI 1%, 75%)], due to the delayed period. The incidence of AEs was higher in the CBM group (86% vs. 67%). No serious AEs were reported. The mean daily dose was 4.8 sprays in both groups.CONCLUSION
Compared with placebo, CBM added to standard antiemetic therapy was well tolerated and provided better protection against delayed CINV. These results should be confirmed in a phase III clinical trial. 相似文献74.
75.
76.
77.
Costabel U Guzman J Bonella F Oshimo S 《Seminars in respiratory and critical care medicine》2007,28(5):514-524
This article reviews the changes in bronchoalveolar lavage (BAL) cytology and cell differentials in some of the rarer interstitial lung diseases. In a few of these diseases BAL has a diagnostic value and can replace lung biopsy. In pulmonary Langerhans cell histiocytosis the characteristic diagnostic finding is an increase in CD1 + Langerhans cells greater than 4% of total cells. The sensitivity of this cutoff value is low because only approximately 50% of patients show this elevation. In pulmonary alveolar proteinosis, the sensitivity of a diagnostic BAL is almost 100%, and the characteristic finding of milky and turbid fluid on gross examination and the characteristic findings with acellular globules that stain pink with PAS (periodic-acid-Schiff), along with abnormal foamy macrophages and a characteristic dirty background obviates the need for lung biopsy. In diffuse alveolar hemorrhage, BAL is the method of choice to diagnose the alveolar bleeding by showing free red blood cells and hemosiderin-laden, iron-positive macrophages. The underlying disorder has to be identified by history and clinical and laboratory tests. In eosinophilic lung disease, the diagnosis can be made if the BAL cell differentials show 25% or more eosinophils. In collagen vascular disease-associated lung fibrosis, the precise role of BAL in assessment and monitoring disease remains unclear. In drug-induced interstitial lung disease BAL may support a certain clinical/pathological pattern of lung involvement and is helpful for exclusion of other diseases, such as malignancies with pulmonary metastasis, heart disease with pulmonary congestion, or infections. The same is true for radiation-induced lung injury. 相似文献
78.
Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease
Tashkin DP Elashoff R Clements PJ Roth MD Furst DE Silver RM Goldin J Arriola E Strange C Bolster MB Seibold JR Riley DJ Hsu VM Varga J Schraufnagel D Theodore A Simms R Wise R Wigley F White B Steen V Read C Mayes M Parsley E Mubarak K Connolly MK Golden J Olman M Fessler B Rothfield N Metersky M Khanna D Li N Li G;Scleroderma Lung Study Research Group 《American journal of respiratory and critical care medicine》2007,176(10):1026-1034
79.
80.
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer with a world-wide annual incidence of around 1.3 million. The majority of patients are diagnosed with advanced disease and survival remains poor. However, relevant advances have occurred in recent years through the identification of biomarkers that predict for benefit of therapeutic agents. This is exemplified by the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the treatment of EGFR mutant patients. These drugs have also shown efficacy in unselected populations but this point remains controversial. Here we have reviewed the clinical data that demonstrate a small but consistent subgroup of EGFR wild-type patients with NSCLC that obtain a clinical benefit from these drugs. Moreover, we review the biological rationale that may explain this benefit observed in the clinical setting. 相似文献